FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


FJ EXPRESS SUMMARY ARTICLE
The
Full-length version of this article is also available, published online January 19, 2006 as doi:10.1096/fj.04-3314fje.
Published as doi: 10.1096/fj.04-3314fje.
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
20/3/476
04-3314fjev1    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gonzalez-Herrera, I. G.
Right arrow Articles by Prats, A.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gonzalez-Herrera, I. G.
Right arrow Articles by Prats, A.-C.
(The FASEB Journal. 2006;20:476-478.)
© 2006 FASEB

Testosterone regulates FGF-2 expression during testis maturation by an IRES-dependent translational mechanism

Irma G. Gonzalez-Herrera*,{dagger},1, Leonel Prado-Lourenco*,{dagger},{ddagger},1, Frédéric Pileur*,{dagger}, Caroline Conte*,{dagger}, Aurélie Morin§, Florence Cabon§, Hervé Prats*,{dagger}, Stephan Vagner*,{dagger}, Francis Bayard*,{dagger},||, Sylvie Audigier*,{dagger} and Anne-Catherine Prats*,{dagger},2

* Institut National de la Santé et de la Recherche Médicale U589, Toulouse, France; Université Paul Sabatier, Toulouse, France;

{dagger} MilleGen, Prologue Biotech, Labège, France;

{ddagger} Laboratoire "Oncogenèse, Différenciation et Transduction du Signal,’ Villejuif, France; and

|| Centre Hospitalier Universitaire de Rangueil, Toulouse, France

2Correspondence: E-mail: pratsac{at}toulouse.inserm.fr

SPECIFIC AIMS

Fibroblast growth factor 2 (FGF-2) is involved in both development and maintenance of testis, especially in gametes production and steroids synthesis. Previous studies have shown that FGF-2 expression is mostly regulated at the translational level, resulting in synthesis of several isoforms with different localizations and functions. The FGF-2 mRNA translation in controlled by an IRES, a structural element in the mRNA leader region allowing translation to occur by a nonclassical mechanism. Few data are available about IRES pathophysiological function, as most studies of IRES regulation have been performed in vitro.

Here we have studied in vivo the physiological role of the FGF-2 IRES in the control of FGF-2 expression during testis development and maintenance of testis function.

PRINCIPAL FINDINGS

1. FGF-2 IRES is age dependently regulated in mouse testis germinal cells
We have developed a unique transgenic animal model to study tissue specificity and regulation of IRES-dependent translation in vivo. This is based on use of a bicistronic vector expressing Renilla luciferase (LucR) and firefly luciferase (LucF), encoded by the same mRNA (Fig. 1 A). The upstream cistron (LucR) is translated via the classical cap-dependent scanning mechanism, whereas translation of the second cistron (LucF) is IRES-driven.


Figure 1
View larger version (62K):
[in this window]
[in a new window]
 
Figure 1. FGF-2 IRES is specifically activated in mouse adult testis spematogonia in correlation with FGF-2 endogenous expression. A) Schema of the bicistronic mRNA expressed by the transgenic mice. B) Luciferase activities were measured in testis extracts of young (3 wk) or adult (6 wk) transgenic mice, and IRES activities calculated as the (LucF/LucR) x 100 ratio. For each IRES, data are expressed relative to the value of the 3 wk testis ratio. C) Immunofluorescence detection with a confocal microscope. Immunofluorescence is superposed with propidium iodure staining. D) Immunohistological staining of 6 wk deparaffinized testis sections (5 µm) with the peroxidase-antiperoxidase technique.

Sexually immature (3 wk postpartum) or mature (6, 12, or 60 wk postpartum) transgenic mice carrying bicistronic transgenes with EMCV, FGF-2, or c-myc IRES were analyzed for IRES activity in testis. The FGF-2 IRES, low at 3 wk, increased up to 6-fold at 6 wk (Fig. 1B ). In contrast, EMCV and c-myc IRES activities remained stable, suggesting that testis maturation is accompanied by a specific activation of the FGF-2 IRES.

To determine which testis cells express LucF in vivo, sections of fresh testes were analyzed by immunohistofluorescent staining (Fig. 1C ) or immunohistochemistry (Fig. 1D ). With both techniques, staining appeared at 6 wk in cells morphologically identified as type A spermatogonias, stem cells of the germinal line, identified by two spermatogonia markers, hnRNPAI and Oct 3/4. Analysis of endogenous FGF-2 revealed specific labeling in spermatogonia at 6 wk; labeling at 3 wk was mostly localized in the interstitial compartment, presumably in Leydig cells. EMCV IRES had a strong activity in blood vessels and interstitial cells in young and adult testis, demonstrating that the LucF expression in adult spermatogonia is due to a physiological control specific to the FGF-2 IRES. Thus, the IRES-dependent mechanism allows a germinal cell-specific activation of FGF-2 expression.

2. FGF-2 IRES activation in adult mice spermatogonia is testosterone-dependent
In immature testis, spermatogenesis is driven by FSH; in the adult this process is controlled by testosterone produced by Leydig cells (Fig. 2 ). Transgenic mice were treated by testosterone at 3 wk postpartum. This resulted in a 5-fold increase of IRES activity, reaching the level observed in mature testis (Fig. 3 A). We also tried to block the testosterone action by using a siRNA directed against the androgen receptor (AR). Results showed a slight but significant decrease of FGF-2 IRES but not of EMCV IRES activity (Fig. 3B , left). FGF-2 expression was also down-regulated in mice treated with AR-siRNA. High molecular weight isoforms known for their intracrine mode of action are specifically concerned by this decrease (Fig. 3B , right).


Figure 2
View larger version (35K):
[in this window]
[in a new window]
 
Figure 2. Proposed physiological role of IRES in the translational control of FGF-2 expression at the start of spermatogenesis in adult testis. Spermatogenesis is a multistep process, where spermatozoa (mature sperm, central region of the tubule) develops from spermatogonia (the stem cells of the germ line lineage in the basal region of the tubule). This process involves complex interactions of germ cells with Sertoli cells within the seminiferous tubule (A). Sertoli cells are able to functionally communicate with the steroid-producing Leydig cells. In adults, Sertoli cells, expressing the androgen receptor, respond to testosterone by triggering spermatogenesis through complex cell-cell interactions with spermatogonia (B). IRES-dependent FGF-2 expression would thus be activated by a stimulus generated by Sertoli cells. Alternatively, spermatogonia might be directly stimulated by testosterone through a membrane receptor. FGF-2 is able to stimulate testosterone synthesis by Leydig cells and able to act on the Sertoli cell function, thus creating a paracrine loop activating spermatogenesis (B). The testosterone-generated signal received by spermatogonia will induce, activate, and/or translocate ITAFs, resulting in formation of an IRESome (RNA-protein complex on the mRNA IRES structure) (C). The IRESome probably involves HnRNPAI, a protein specifically expressed in spermatogonia and recently characterized as an ITAF of the FGF-2 IRES. IRES activation leads to synthesis of the CUG- and AUG-initiated FGF-2 isoforms. The AUG-initiated form is secreted and has a paracrine function; CUG-initiated isoforms are nuclear and are involved in an intracrine function of FGF-2 in the start of spermatogenesis (mitosis or meiosis initiation).


Figure 3
View larger version (54K):
[in this window]
[in a new window]
 
Figure 3. FGF-2 IRES regulation by testosterone and anti-androgen receptor siRNA. A) 3-wk-old transgenic male mice treated with testosterone. Left: IRES activities in testes of young mice treated with testosterone (3W+T) and of adult mice without treatment (6W) are expressed relative to the untreated young mice control (3W). Middle left: Measurement of luciferase activities in testes of 3 wk mice treated or not with testosterone. Middle right: Expression of the 2 cistron LucR and LucF measured by real-time PCR using 2 distinct primer couples. Right: Endogenous FGF-2 expression detected by Western immunoblot analysis with anti-FGF-2 anti-body at 3 wk with or without testosterone treatment. B) Androgen receptor was targeted using an AR-siRNA. Transgenic adult mice expressing transgenes with FGF-2 or EMCV IRES were treated for 10 days by i.p. siRNA injection. IRES activities are expressed as % of control (cont-siRNA). AR depletion was checked by Western immunoblot analysis (right panel) as well as levels of endogenous FGF-2 and tubulin. C) UV cross-linking of testis proteins bound to the FGF-2 mRNA 5' UTR. *Proteins found in immature testis but not in adult testis or in immature testis treated with testosterone. Light arrows indicate proteins cross-linked to the FGF-2 IRES in adult and testosterone-treated prepubertal testes. Heavy arrow indicates the only protein bound to the FGF-2 mRNA 5' UTR in testicular extracts of adult mice but not in immature testis with or without testosterone treatment.

3. Testosterone induces protein binding to the FGF-2 mRNA 5' UTR
Testicular extracts of 3 and 6 wk-old mice were used for cross-linking experiments with RNA probe corresponding to the FGF-2 5' UTR RNA (containing the IRES), and analyzed by 2-dimensional gel electrophoresis (Fig. 2C ). A different profile of bound testicular proteins was observed at 3 or 6 wk. Extracts of testosterone-treated immature mice testis showed the same profile as that observed in adults. Such a correlation between changes of protein binding and FGF-2 IRES activity increase asks the question of the involvement of specific ITAFs (IRES-trans-acting factors) in the IRES-dependent control of FGF-2 expression at the start of spermatogenesis. In fact, hnRNAPI was recently shown as an activating ITAF of the FGF-2 IRES.

CONCLUSIONS AND SIGNIFICANCE

The present report describes one of the first IRES-mediated regulations of gene expression in a physiological process.

In mature testis, FGF-2 expression is transcriptionally down-regulated. Here we show that in such conditions the IRES-dependent translational mechanism allows specific expression of FGF-2 in spermatogonia. As FGF-2 is crucial at the start of spermatogenesis, the IRES-dependent mechanism appears as an alternative, in the absence of FGF-2 produced by the paracrine way, to trigger spermatogonia proliferation and/or differentiation toward the spermatogenesis process.

Another novel finding is the hormonal control of the FGF-2 IRES activity. Adult spermatogenesis is controlled by Leydig cells-produced testosterone. We show that testosterone triggers activation of the FGF-2 IRES, in a period coinciding with emergence of Leydig cell function. This testosterone-dependent regulation is fully consistent with the IRES activation observed in adult but not in immature spermatogonia. It has been shown that FGF-2 expressed by germ line cells induces testosterone production by Leydig cells. Thus, the IRES would be implied in the emergence of a paracrine loop leading to spermatogenesis in mature testis (Fig. 2B ).

AR depletion using siRNA was able to partially suppress IRES activation. This partial effect can be explained by the 70% efficiency of AR depletion. AR, although pivotal for adult spermatogenesis, is not expressed by spermatogonia but by Sertoli cells. Thus, testosterone presumably acts indirectly, through cell-cell communication between Sertoli cells and spermatogonia. An alternative hypothesis is that activation of FGF-2 expression might be mediated by nongenomic effects of testosterone involving a membrane receptor.

Another feature of FGF-2 expression in spermatogonia is the synthesis of FGF-2 high molecular weight isoforms. Such isoforms have been described in germ cells, and we show here that AR siRNA blocks expression of the high molecular weight isoforms. Thus, expression of HMW nuclear FGF-2 might have a role in the start of spermatogenesis by an intracrine process (Fig. 2B ).

Regulation of the FGF-2 IRES activity involves participation of regulatory proteins, IRES trans-acting factors (ITAFs), acting as repressors or activators: we have recently shown that this IRES is negatively regulated by p53 while activated by HnRNPA1. The proteins bound to the FGF-2 IRES are putative ITAFs. These ITAFs would be induced, activated, or translocated in response to a stimulus coming from Sertoli cells, leading to formation of an RNA-protein complex called "IRESome," which would activate the IRES and increase FGF-2 expression (Fig. 2C ). Translational control plays a central role in the meiotic stages of spermatogenesis, but little is known about translational control during mitosis occurring in the pre-meiotic stages. In fact, FGF-2 may not only act as a mitogenic factor but also as a differentiation factor.

The finding of IRES-dependent regulation in a crucial process such as spermatogenesis highlights the relevance of cellular mRNA IRESs in the control of gene expression in various pathophysiological processes.

FOOTNOTES

1 These authors contributed equally to this work.

To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.04-3314fje;




This article has been cited by other articles:


Home page
RNAHome page
S. Audigier, J. Guiramand, L. Prado-Lourenco, C. Conte, I. G. Gonzalez-Herrera, C. Cohen-Solal, M. Recasens, and A.-C. Prats
Potent activation of FGF-2 IRES-dependent mechanism of translation during brain development
RNA, September 1, 2008; 14(9): 1852 - 1864.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
20/3/476
04-3314fjev1    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gonzalez-Herrera, I. G.
Right arrow Articles by Prats, A.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gonzalez-Herrera, I. G.
Right arrow Articles by Prats, A.-C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS